CSS LLC’s Cidara Therapeutics CDTX Stock Holding History

CSS LLC’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$663K	–	1014
2025 Q4	$663K	Buy	+3,000	New	+$485K	0.03%	451

CSS LLC's CDTX Position: Q1 2026 in Review

CSS LLC sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 13,500 shares — an estimated $2.98M sold.

CSS LLC first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $2.98M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

CSS LLC reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
CSS LLC sold 13,500 Cidara Therapeutics shares in Q1 2026, an estimated $2.98M.
CSS LLC first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
CSS LLC's Cidara Therapeutics position peaked at $2.98M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.